000 01447 a2200409 4500
005 20250515140849.0
264 0 _c20090521
008 200905s 0 0 spa d
022 _a0210-5691
024 7 _a10.1016/s0210-5691(08)76217-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPortilla-Botelho, M
245 0 0 _a[Paroxetine-induced severe hyponatremic rhabdomyolisis].
_h[electronic resource]
260 _bMedicina intensiva
_cOct 2008
300 _a365-6 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aCations
_xmetabolism
650 0 4 _aComa
_xblood
650 0 4 _aDepressive Disorder
_xdrug therapy
650 0 4 _aDiagnosis, Differential
650 0 4 _aEpilepsy, Tonic-Clonic
_xblood
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyponatremia
_xchemically induced
650 0 4 _aLorazepam
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aMuscle Cells
_xmetabolism
650 0 4 _aParoxetine
_xadministration & dosage
650 0 4 _aRhabdomyolysis
_xblood
650 0 4 _aSaline Solution, Hypertonic
_xtherapeutic use
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
700 1 _aOrtega-Carnicer, J
700 1 _aGómez-Grande, M L
700 1 _aMartín-Rodríguez, C
773 0 _tMedicina intensiva
_gvol. 32
_gno. 7
_gp. 365-6
856 4 0 _uhttps://doi.org/10.1016/s0210-5691(08)76217-x
_zAvailable from publisher's website
999 _c18308085
_d18308085